Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau*

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Biological Chemistry

• Publication date

  2014-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M114.565358PMID 25128526PMCID PMC4183805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models

  2014cited by this paper
• SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients.

  2014cited by this paper
• Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection

  2014cited by this paper
• Protein phosphatase 2A dysfunction in Alzheimer’s disease

  2014cited by this paper
• Cytoplasmic targeting of the proto‐oncogene SET promotes cell spreading and migration

  2013cited by this paper
• Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.

  2013cited by this paper
• Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease*

  2013cited by this paper
• Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)*

  2012cited by this paper
• An experimental rat model of sporadic Alzheimer’s disease and rescue of cognitive impairment with a neurotrophic peptide

  2011cited by this paper
• Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2 PP2A/SET

  2011cited by this paper
• The carboxy‐terminal fragment of inhibitor‐2 of protein phosphatase‐2A induces Alzheimer disease pathology and cognitive impairment

  2010cited by this paper
• Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.

  2010influential reference
• Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration*

  2010cited by this paper
• The propagation of prion-like protein inclusions in neurodegenerative diseases.

  2010cited by this paper
• Protein Phosphatase 2A Facilitates Axonogenesis by Dephosphorylating CRMP2

  2010cited by this paper
• Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice

  2010cited by this paper
• Regulation of GSK3 isoforms by phosphatases PP1 and PP2A

  2010cited by this paper
• PP2A Regulates Tau Phosphorylation Directly and also Indirectly via Activating GSK-3β

  2010cited by this paper
• From promiscuity to precision: protein phosphatases get a makeover.

  2009cited by this paper
• Mechanisms of tau-induced neurodegeneration

  2009cited by this paper
• Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology

  2009cited by this paper
• I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A*

  2008cited by this paper
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

  2008cited by this paper
• Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation*

  2008cited by this paper
• Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome*♦

  2008cited by this paper
• Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms.

  2008cited by this paper
• The nuclear localization of SET mediated by impα3/impβ attenuates its cytosolic toxicity in neurons

  2007cited by this paper
• Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease

  2007cited by this paper
• Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau

  2007cited by this paper
• Rac1‐induced cell migration requires membrane recruitment of the nuclear oncogene SET

  2007cited by this paper
• The nuclear localization of SET mediated by impalpha3/impbeta attenuates its cytosolic toxicity in neurons.

  2007cited by this paper
• Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

  2007cited by this paper
• Involvement of in the abnormal hyperphosphorylation of tau and its reversal by Memantine

  2006cited by this paper
• Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.

  2006cited by this paper
• Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.

  2006cited by this paper
• SET protein (TAF1β, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain

  2005cited by this paper
• Post-translational modifications of tau protein in Alzheimer’s disease

  2005cited by this paper
• The oncoprotein I-2PP2A/SET negatively regulates the MEK/ERK pathway and cell proliferation.

  2005cited by this paper
• Metabolic/signal transduction hypothesis of Alzheimer’s disease and other tauopathies

  2005cited by this paper
• Inhibitors of protein phosphatase‐2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau

  2005cited by this paper
• Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.

  2005cited by this paper
• Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation

  2005cited by this paper
• Multiple Nuclear Localization Sequences Allow Modulation of 5‐Lipoxygenase Nuclear Import

  2004cited by this paper
• Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis

  2004cited by this paper
• O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

  2004cited by this paper
• The SET Protein Regulates G2/M Transition by Modulating Cyclin B-Cyclin-dependent Kinase 1 Activity*

  2003cited by this paper
• Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.

  2003cited by this paper
• Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3.

  2002cited by this paper
• Inhibition of PP‐2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356

  2001cited by this paper
• Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Balpha regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen.

  2001cited by this paper
• Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments

  2001cited by this paper
• Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.

  2001cited by this paper
• Protein phosphatase 2A inhibitors, I(1)(PP2A) and I(2)(PP2A), associate with and modify the substrate specificity of protein phosphatase 1.

  2000cited by this paper
• Protein Phosphatase 2A Inhibitors, I1 PP2A and I2 PP2A, Associate with and Modify the Substrate Specificity of Protein Phosphatase 1*

  2000cited by this paper
• Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis.

  2000cited by this paper
• Expression of SET is modulated as a function of cell proliferation

  1999cited by this paper
• Dynamic Regulation of Expression and Phosphorylation of Tau by Fibroblast Growth Factor-2 In Neural Progenitor Cells from Adult Rat Hippocampus

  1999cited by this paper
• Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.

  1998cited by this paper
• Ser‐262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK

  1998cited by this paper
• Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau.

  1997cited by this paper
• Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated τ by neuroleptics

  1996cited by this paper
• Calcium/calmodulin‐dependent protein kinase II phosphorylates tau at Ser‐262 but only partially inhibits its binding to microtubules

  1996cited by this paper
• The Myeloid Leukemia-associated Protein SET Is a Potent Inhibitor of Protein Phosphatase 2A (*)

  1996cited by this paper
• Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics.

  1996cited by this paper
• Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules

  1996cited by this paper
• Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney.

  1995cited by this paper
• Modulation of GSK‐3‐catalyzed phosphorylation of microtubule‐associated protein tau by non‐proline‐dependent protein kinases

  1995cited by this paper
• Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*)

  1995cited by this paper
• Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain

  1995cited by this paper
• Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

  1994cited by this paper
• The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo.

  1994cited by this paper
• Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

  1993cited by this paper
• Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain

  1993cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation.

  1992cited by this paper
• Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.

  1992cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper

• The CD97-PPM1G axis dampens antiviral immunity by dephosphorylating IRF7 in type I interferon pathway.

  2026cites this paper
• The next decade of SET: from an oncoprotein to beyond

  2023cites this paper
• Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A

  2023influential citation
• PP2A is activated by cytochrome c upon formation of a diffuse encounter complex with SET/TAF-Iβ

  2022cites this paper
• The role of protein phosphatase 2A tau axis in traumatic brain injury therapy

  2022cites this paper
• Biomarker Candidates for Alzheimer’s Disease Unraveled through In Silico Differential Gene Expression Analysis

  2022cites this paper
• Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer’s disease

  2022cites this paper
• Brown adipose tissue and alzheimer’s disease

  2022cites this paper
• Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients

  2021cites this paper
• Zinc Finger Proteins in Neuro-Related Diseases Progression

  2021cites this paper
• MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and Other Chronic Diseases

  2021cites this paper
• Advance of sporadic Alzheimer's disease animal models

  2020cites this paper
• Prostaglandin A1 inhibits the phosphorylation of tau via activating protein phosphotase 2A in a michael addition mechanism at the site of cysteine 377

  2020cites this paper
• IN HIPPOCAMPAL NEURONS DURING TRANSCRIPTION-DEPENDENT

  2020cites this paper
• Transmembrane Peptides as a New Strategy to Inhibit Neuraminidase-1 Activation

  2020cites this paper
• LOCAL REGULATION AND FUNCTION OF IMPORTIN-β1 IN HIPPOCAMPAL NEURONS DURING TRANSCRIPTION-DEPENDENT PLASTICITY

  2020cites this paper
• Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377

  2020cites this paper
• Blockage of AEP attenuates TBI-induced tau hyperphosphorylation and cognitive impairments in rats

  2020cites this paper
• Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

  2020cites this paper
• Discovering the genes mediating the interactions between chronic respiratory diseases in the human interactome

  2020cites this paper
• Clinical phenotype and genetic risk factors for bipolar disorder with binge eating: an update

  2019cites this paper
• PP2ACα of Alveolar Macrophages Is a Novel Protective Factor for LPS-Induced Acute Respiratory Distress Syndrome

  2019cites this paper
• Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium

  2019cites this paper
• Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease

  2019cites this paper
• To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling

  2019cites this paper
• Distribution of SET/I2PP2A protein in gastrointestinal tissues

  2019cites this paper
• SE translation mRNA overexpression: a potential prognostic predictor in breast cancer

  2019cites this paper
• Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species

  2018cites this paper
• Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury

  2018cites this paper
• Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca2+ overload, as a multitarget strategy for the treatment of Alzheimer's disease.

  2018cites this paper
• Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8

  2018cites this paper
• A comprehensive and perspective view of oncoprotein SET in cancer

  2018cites this paper
• Analysis of ATP-Dependent Chaperone Protein Interactions with Misfolded Proteins, Amyloids, and Aggregated Proteins

  2018cites this paper
• CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment

  2018cites this paper
• Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation

  2018cites this paper
• Role of microtubule-associated protein tau phosphorylation in Alzheimer’s disease

  2017cites this paper
• SET/I2PP2A overexpression induces phenotypic, molecular, and metabolic alterations in an oral keratinocyte cell line

  2017cites this paper
• Phosphorylation of KLC1 modifies interaction with JIP1 and abolishes the enhanced fast velocity of APP transport by kinesin-1

  2017cites this paper
• The role of TIGAR in Parkinson´s Disease

  2017cites this paper
• Pathologic significance of SET/I2PP2A-mediated PP2A and non-PP2A pathways in polycystic ovary syndrome (PCOS).

  2017cites this paper
• Role of microtubule-associated protein tau phosphorylation in Alzheimer’s disease

  2017cites this paper
• Long-Term Dietary Supplementation with Selenium-Enriched Yeast Improves Cognitive Impairment, Reverses Synaptic Deficits, and Mitigates Tau Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease.

  2017cites this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cites this paper
• Oncogenic Role of SET/I2PP2A for Gynecologic Cancers.

  2017cites this paper
• Soluble Amyloid Precursor Protein Alpha Interacts with alpha3-Na, K-ATPAse to Induce Axonal Outgrowth but Not Neuroprotection: Evidence for Distinct Mechanisms Underlying these Properties

  2017cites this paper
• Research Progress in Oncology. Highlighting and Exploiting the Roles of Several Strategic Proteins in Understanding Cancer Biology

  2016cites this paper
• MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia

  2016cites this paper
• Follicle-Stimulating Hormone (FSH)-dependent Regulation of Extracellular Regulated Kinase (ERK) Phosphorylation by the Mitogen-activated Protein (MAP) Kinase Phosphatase MKP3 *

  2016cites this paper
• Regulation of SET Gene Expression by NFkB

  2016cites this paper
• Tau Phosphorylation as a Therapeutic Target in Alzheimer’s Disease

  2016cites this paper
• Zinc Finger and X-Linked Factor (ZFX) Binds to Human SET Transcript 2 Promoter and Transactivates SET Expression

  2016cites this paper
• The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease

  2015cites this paper
• Growth factor treatment to overcome Alzheimer's dysfunctional signaling.

  2015cites this paper
• Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis

  2015cites this paper
• GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner

  2015cites this paper
• The Cascade of Oxidative Stress and Tau Protein Autophagic Dysfunction in Alzheimer’s Disease

  2015influential citation
• Cyclin‐Dependent kinase 5 targeting prevents β‐Amyloid aggregation involving glycogen synthase kinase 3β and phosphatases

  2015cites this paper
• Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation*

  2015influential citation